Skip to main content
. 2023 Feb 6;15(2):451. doi: 10.3390/v15020451

Figure 2.

Figure 2

Meta-analysis of the HPV+ OCSCC prevalence in the included studies, representing the present HPV+ OCSCC prevalence worldwide [19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,44,45,46,47,48,49]. HPV+: human papillomavirus positive. OCSCC: oral cavity squamous cell carcinoma. 95% C.I: confidence interval.